Inactive Instrument
Earth Science Tech, Inc. Stock Other OTC
Stocks
ETST
US2703111037
Pharmaceuticals
OTC Markets Traded| Market Cap | 46.11M 40.43M 37.26M 34.89M 65.42M 4.35B 66.78M 448M 173M 2.15B 173M 169M 7.45B | P/E 2027 * |
5.33x | P/E 2028 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 46.11M 40.43M 37.26M 34.89M 65.42M 4.35B 66.78M 448M 173M 2.15B 173M 169M 7.45B | EV / Sales 2027 * |
1.07x | EV / Sales 2028 * | 1.05x |
| Free-Float |
33.3% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Earth Science Tech, Inc.
| 1 day | -5.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 46 | 2023-02-12 |
Ernesto Flores
DFI | Director of Finance/CFO | 41 | 2024-03-03 |
Mario Tabraue
PSD | President | 47 | 2021-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mario Tabraue
BRD | Director/Board Member | 47 | 2021-10-31 |
Jeff Cazeau
BRD | Director/Board Member | 58 | 2023-02-12 |
Giorgio Saumat
CHM | Chairman | 46 | 2022-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.08% | -10.57% | - | - | 43.23M | ||
| +7.13% | +9.97% | +51.94% | +166.83% | 1,006B | ||
| +3.99% | +11.50% | +67.53% | +55.63% | 589B | ||
| +4.20% | +17.03% | +35.63% | +87.74% | 430B | ||
| +0.99% | +4.85% | +27.93% | +22.82% | 331B | ||
| +1.82% | +8.19% | +41.15% | +26.80% | 288B | ||
| +0.22% | +6.75% | +31.51% | +42.02% | 285B | ||
| +0.73% | +8.53% | -26.22% | -40.85% | 213B | ||
| +1.56% | +6.14% | +28.38% | +59.45% | 190B | ||
| +3.26% | +3.33% | +18.83% | +67.03% | 154B | ||
| Average | +1.35% | +8.46% | +30.74% | +54.16% | 387.31B | |
| Weighted average by Cap. | +2.25% | +9.14% | +40.20% | +79.88% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.99M 37.69M 34.74M 32.53M 60.99M 4.05B 62.26M 418M 162M 2B 161M 158M 6.95B | 43.98M 38.56M 35.55M 33.28M 62.4M 4.15B 63.7M 427M 165M 2.05B 165M 162M 7.11B |
| Net income | - | 4.94 4.34 4 3.74 7.02 466.47 7.16 48.04 18.59 230.54 18.57 18.16 799.42 |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals

















